Re: Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, Oster P, O'Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D. Vaccine 2007;25(16):3075-9.
作者信息
Lennon Diana
出版信息
Vaccine. 2007 Sep 28;25(39-40):6835; author reply 6835-6. doi: 10.1016/j.vaccine.2007.06.025. Epub 2007 Jun 19.
Abstract
摘要
相似文献
1
Re: Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, Oster P, O'Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D. Vaccine 2007;25(16):3075-9.
Vaccine. 2007 Sep 28;25(39-40):6835; author reply 6835-6. doi: 10.1016/j.vaccine.2007.06.025. Epub 2007 Jun 19.
2
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand.
Vaccine. 2007 Apr 20;25(16):3075-9. doi: 10.1016/j.vaccine.2007.01.023. Epub 2007 Jan 22.
3
Re: Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease, Nokleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P. Vaccine 2007;25(16):3080-4.
Vaccine. 2007 Sep 28;25(39-40):6833; author reply 6833-4. doi: 10.1016/j.vaccine.2007.06.024. Epub 2007 Jun 21.
4
Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.
Clin Vaccine Immunol. 2007 Jul;14(7):830-8. doi: 10.1128/CVI.00039-07. Epub 2007 May 9.
5
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
Pediatr Infect Dis J. 2007 Apr;26(4):345-50. doi: 10.1097/01.inf.0000258697.05341.2c.
6
Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.
Vaccine. 2007 Apr 20;25(16):3080-4. doi: 10.1016/j.vaccine.2007.01.022. Epub 2007 Jan 22.
7
Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.
Vaccine. 2006 Feb 27;24(9):1395-400. doi: 10.1016/j.vaccine.2005.09.043. Epub 2005 Oct 4.
8
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
Pediatr Infect Dis J. 2010 Nov;29(11):e71-9. doi: 10.1097/INF.0b013e3181f59f6d.
9
Recent developments in vaccines to prevent meningococcal serogroup B infections.
Curr Opin Mol Ther. 2003 Feb;5(1):33-8.
10
Prevention of group B meningococcal disease by vaccination: a difficult task.
N Z Med J. 2004 Aug 20;117(1200):U1016.
Zotero 插件